Search Result "KRAS G12C"
First Approval of Adagrasib for the Treatment of Non-Small CellLung Cancer Harboring a KRASG12C Mutation
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 3 Year: 2024 Page: 266-272
Author(s): Surya K. De
Recent Developments, Challenges and Opportunities in Targeting theKRAS Pathway
Journal: Letters in Drug Design & Discovery
Volume: 20 Issue: 8 Year: 2023 Page: 992-1004
Author(s): Manoj Kumar Pothuganti
Targeting Mutant KRAS for Anticancer Therapy
Journal: Current Topics in Medicinal Chemistry
Volume: 19 Issue: 23 Year: 2019 Page: 2098-2113
Author(s): Fengqian Chen,Martin P. Alphonse,Yan Liu,Qi Liu
The Patent Landscape of BRAF Target and KRAS Target
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 18 Issue: 4 Year: 2023 Page: 495-505
Author(s):
Selumetinib in Advanced Non Small Cell Lung Cancer (NSCLC) Harbouring KRAS Mutation: Endless Clinical Challenge to KRAS-mutant NSCLC.
Journal: Reviews on Recent Clinical Trials
Volume: 8 Issue: 2 Year: 2013 Page: 93-100
Author(s): Paolo Maione,Assunta Sgambato,Antonio Rossi,Paola Claudia Sacco,Maria Anna Bareschino,Clorinda Schettino,Francesca Casaluce,Fortunato Ciardiello,Cesare Gridelli
Drug Combinatorial Therapies for the Treatment of KRAS Mutated Lung Cancers
Journal: Current Topics in Medicinal Chemistry
Volume: 19 Issue: 23 Year: 2019 Page: 2128-2142
Author(s): Hao He,Chang Xu,Zhao Cheng,Xiaoying Qian,Lei Zheng
Overview of Current Immunotherapies Targeting Mutated KRAS Cancers
Journal: Current Topics in Medicinal Chemistry
Volume: 19 Issue: 23 Year: 2019 Page: 2158-2175
Author(s): Winfrey Pui Yee Hoo,Pui Yan Siak,Lionel L.A. In
Are KRAS/BRAF Mutations Potent Prognostic and/or Predictive Biomarkers in Colorectal Cancers?
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12 Issue: 2 Year: 2012 Page: 163-171
Author(s): Tomoya Yokota
KRAS Mutations in Lung Adenocarcinoma: Molecular and Epidemiological Characteristics, Methods for Detection, and Therapeutic Strategy Perspectives
Journal: Current Molecular Medicine
Volume: 15 Issue: 5 Year: 2015 Page: 418-432
Author(s): N. Guibert,M. Ilie,E. Long,V. Hofman,L. Bouhlel,P. Brest,B. Mograbi,C.H. Marquette,A. Didier,J. Mazieres,P. Hofman
Novel 1,4-Dihydropyrido[2,3-B]Pyrazine-2,3-Dione Derivatives for Treating Cancerand Other Disorders Associated with KRAS Activity
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 23 Issue: 8 Year: 2023 Page: 979-980
Author(s): Surya K. De